Drug Overdose and Toxicology
Drug overdose and poisoning are common emergency presentations. Knowledge of specific antidotes, risk assessment tools, and management protocols is essential for safe clinical practice.
Key Facts
Paracetamol overdose is the commonest cause of acute liver failure in the UK — use the treatment nomogram and give N-acetylcysteine (NAC) TOXBASE (National Poisons Information Service) is the UK's primary clinical toxicology database for management guidance Activated charcoal (50g PO) is effective if given within 1 hour of ingestion of most toxins Opioid overdose: Pinpoint pupils, respiratory depression → naloxone 400mcg IV/IM, repeat as needed Tricyclic antidepressant overdose: Broad QRS, seizures, arrhythmias → sodium bicarbonate 8.4% (1-2 mEq/kg IV) Benzodiazepine overdose: Rarely fatal in isolation → flumazenil (use cautiously — seizure risk in mixed overdose/chronic use) Salicylate (aspirin) overdose: Tinnitus, mixed respiratory alkalosis + metabolic acidosis → alkaline diuresis, haemodialysis if severe Staggered paracetamol overdoses are highest risk — always treat with NAC if >75mg/kg over 24 hours
Overview
Key Facts
Poisoning accounts for over 170,000 hospital presentations per year in England. It is the leading cause of death in young adults (15-35 years) and is frequently associated with mental health conditions and substance misuse.
Epidemiology
- >100,000 ED attendances for self-poisoning per year in England
- Paracetamol is involved in ~50% of poisoning presentations
- ~5,000 deaths from poisoning per year in the UK (including drug misuse deaths)
- Self-poisoning accounts for ~80% of self-harm hospital presentations
Aetiology
- Intentional self-harm: ~80% of poisoning presentations (impulsive in many)
- Accidental ingestion: Especially in children under 5 years
- Recreational drug use: MDMA, cocaine, novel psychoactive substances
- Iatrogenic: Medication errors, drug interactions
Pathophysiology
Mechanisms of toxicity depend on the agent:
- Paracetamol: NAPQI (toxic metabolite) depletes glutathione → hepatocyte necrosis
- Opioids: Mu-receptor agonism → respiratory depression
- Tricyclics: Sodium channel blockade (broad QRS), anticholinergic effects, alpha-blockade
- Salicylates: Uncoupling of oxidative phosphorylation, direct CNS stimulation
- Organophosphates: Irreversible acetylcholinesterase inhibition
Clinical Presentation
Toxidromes
- Sympathomimetic (cocaine, amphetamines): Tachycardia, hypertension, hyperthermia, mydriasis, agitation
- Anticholinergic (TCAs, antihistamines): 'Hot as a hare, blind as a bat, dry as a bone, red as a beet, mad as a hatter'
- Cholinergic (organophosphates): SLUDGE — Salivation, Lacrimation, Urination, Defaecation, GI distress, Emesis
- Opioid: Pinpoint pupils, respiratory depression, reduced consciousness
- Serotonin syndrome: Clonus, agitation, hyperthermia, hyperreflexia
Red Flags
- Altered consciousness (GCS <8 — protect airway)
- Respiratory rate <12 or >25
- Seizures
- Cardiac arrhythmias (prolonged QRS >120ms or QTc >500ms)
- Metabolic acidosis (pH <7.30)
- Liver failure features (coagulopathy, encephalopathy) in paracetamol overdose
Differential Diagnosis
| Diagnosis | Key Features | Investigation |
|---|---|---|
| Paracetamol overdose | Asymptomatic early, RUQ pain later, liver failure | Paracetamol level (4h+), LFTs, INR |
| Opioid overdose | Pinpoint pupils, bradypnoea | Response to naloxone, urine toxicology |
| TCA overdose | Anticholinergic features, seizures, broad QRS | ECG (QRS >100ms), blood levels |
| Salicylate overdose | Tinnitus, hyperventilation | Salicylate level, ABG |
| Benzodiazepine overdose | Drowsiness, rarely respiratory depression alone | Clinical response to flumazenil (if safe) |
| Carbon monoxide poisoning | Headache, cherry-red skin (late), confusion | Carboxyhaemoglobin level |
| Alcohol intoxication | Altered behaviour, ataxia, reduced GCS | Blood alcohol level, exclude head injury |
Diagnosis / Investigation
Bedside
- A-E assessment: ABCDE approach, ensure airway protection
- ECG: QRS duration (TCA), QTc (many drugs), ST changes
- Blood glucose: Hypoglycaemia (insulin, sulfonylureas, alcohol)
- Temperature: Hyperthermia (serotonin syndrome, NMS, sympathomimetics)
Bloods
- Paracetamol level: At 4 hours post-ingestion (or ASAP if staggered)
- Salicylate level: If suspected
- ABG/VBG: Acid-base status, lactate, carboxyhaemoglobin
- U&Es: Renal function, potassium
- LFTs and INR: Hepatotoxicity assessment
- FBC, glucose, CRP: Baseline
Imaging
- CXR: Aspiration pneumonitis, pulmonary oedema
- CT head: If reduced consciousness and diagnosis uncertain, or suspected head injury
Special Tests
- Urine drug screen: Cocaine, opioids, benzodiazepines, amphetamines
- TOXBASE consultation: For specific agent guidance
- Carboxyhaemoglobin: CO poisoning (take sample before O2 therapy if possible)
Management
Non-pharmacological
- Airway protection: Intubation if GCS <8
- Activated charcoal: 50g PO within 1 hour of ingestion (most toxins)
- Whole bowel irrigation: Sustained-release preparations, body packers
Pharmacological
Specific antidotes:
- Paracetamol → N-acetylcysteine (NAC): 150mg/kg in 200mL 5% dextrose over 1h, then 50mg/kg over 4h, then 100mg/kg over 16h
- Opioids → Naloxone: 400mcg IV, repeat every 2-3 min (max 10mg); consider infusion (short half-life)
- Benzodiazepines → Flumazenil: 200mcg IV, then 100mcg every 60s (max 2mg) — caution in chronic use/mixed OD
- TCAs → Sodium bicarbonate 8.4%: 50mL IV if QRS >120ms or arrhythmias
- Beta-blockers → Glucagon: 2-10mg IV bolus, then infusion
- Organophosphates → Atropine (high dose) + pralidoxime
- Digoxin → DigiFab: Digoxin-specific antibody fragments
- Iron → Desferrioxamine: 15mg/kg/h IV
- Methanol/ethylene glycol → Fomepizole (or ethanol infusion) + haemodialysis
Surgical/Interventional
- Haemodialysis: Lithium, salicylates, methanol, ethylene glycol, theophylline
- Intralipid (lipid emulsion): Local anaesthetic toxicity, lipophilic drug overdose
Referral Criteria
- All intentional self-harm → psychiatric assessment before discharge
- Severe poisoning → ICU/toxicology
- Paracetamol with high-risk features → liver unit (King's College criteria)
- National Poisons Information Service (NPIS): 0344 892 0111
Prognosis
- Paracetamol overdose: Mortality <1% if NAC given within 8 hours; ~5% mortality with established liver failure
- Opioid overdose: Excellent prognosis with timely naloxone administration
- TCA overdose: Mortality 2-5% in severe cases; most deaths from arrhythmias
- Overall poisoning mortality in hospital: <1% with appropriate management
- Risk of repeat self-harm within 1 year: ~25%; suicide risk ~3% over 5 years
Other Relevant Information
Key Antidotes Summary
| Toxin | Antidote | Key Notes |
|---|---|---|
| Paracetamol | N-acetylcysteine (NAC) | Use nomogram; treat staggered OD |
| Opioids | Naloxone | Short t½ — may need infusion |
| Benzodiazepines | Flumazenil | Avoid in chronic use/mixed OD |
| TCAs | Sodium bicarbonate | Target QRS narrowing |
| Warfarin | Vitamin K / PCC | PCC for major bleeding |
| Heparin | Protamine | 1mg per 100 units heparin |
| Beta-blockers | Glucagon | Bypasses beta receptor |
| Calcium channel blockers | Calcium chloride/gluconate + high-dose insulin | HDI with dextrose |
| Digoxin | DigiFab | Number of vials = digoxin level × weight / 100 |
| Iron | Desferrioxamine | If serum iron >90 µmol/L |
King's College Criteria for Liver Transplant (Paracetamol)
| Criteria |
|---|
| Arterial pH <7.30 after resuscitation |
| OR all three of: INR >6.5, creatinine >300 µmol/L, grade III-IV encephalopathy |